Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Fanconi Anemia Clinical Trials
Fanconi Anemia clinical trials are recruiting across 203 cities. Here are the cities with the most active studies:
Fanconi Anemia Trial Phases
75 research organizations are sponsoring fanconi anemia trials.
About Fanconi Anemia
Fanconi anemia is a rare genetic disorder that affects bone marrow, reducing production of all types of blood cells and increasing cancer susceptibility. It is associated with physical abnormalities and organ defects. Treatment includes blood transfusions, growth factors, and stem cell transplant.
Clinical trials are advancing new treatments for fanconi anemia. Currently, 100 studies are recruiting a combined 861,490 participants across the United States. Research is being conducted by 75 organizations including Children's Hospital of Philadelphia, American Heart Association, NICHD Neonatal Research Network and 72 others.
2026 Fanconi Anemia Research Landscape
As of July 2026, the fanconi anemia clinical trial landscape includes 100 actively recruiting studies across 203 cities in the United States. These studies are collectively seeking 861,490 participants, with an average enrollment target of 8,615 per study.
The research spans multiple phases of development: 37 studies are in NA, 18 studies are in PHASE3, 2 studies are in PHASE4. The presence of Phase 3 trials indicates that some fanconi anemia treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 75 different organizations, including Children's Hospital of Philadelphia, American Heart Association, NICHD Neonatal Research Network, University Hospitals Cleveland Medical Center, Center for International Blood and Marrow Transplant Research, and 70 others. The large number of sponsors reflects significant research interest and investment in fanconi anemia treatment advancement.
Geographically, fanconi anemia trials are most concentrated in Birmingham, Alabama (15 trials); Chicago, Illinois (15 trials); Los Angeles, California (14 trials); Phoenix, Arizona (13 trials); Little Rock, Arkansas (12 trials) and 7 other cities.
Featured Fanconi Anemia Studies
Highlighted recruiting studies for fanconi anemia, selected by enrollment size and research scope.
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
Advanced airway interventions are common high risk, high stakes events for children in intensive care units (ICU) and emergency departments (ED), with risk for life and health threatening consequences.
Get With The Guidelines-Heart Failure Registry
Get With The Guidelines-Heart Failure is designed to improve the quality of care in patients hospitalized with heart failure. The program aims to help ensure that eligible patients are initiated on guideline recommended therapies and receive appropriate counseling prior to hospital discharge.
Generic Database of Very Low Birth Weight Infants
The Generic Database (GDB) is a registry of very low birth weight infants born alive in NICHD Neonatal Research Network (NRN) centers. The GDB collects observational baseline data on both mothers and infants, and the therapies used and outcomes of the infants. The information collected is not specific to a disease or treatment (i.e., it is "generic"). Data are analyzed to find associations and tre...
Frequently Asked Questions About Fanconi Anemia Clinical Trials
Are there fanconi anemia clinical trials near me?
Yes, there are 100 fanconi anemia clinical trials currently recruiting across 203+ cities in the United States, including Birmingham, Alabama; Chicago, Illinois; Los Angeles, California. Browse the studies above to find one at a location convenient for you.
How do I join a fanconi anemia clinical trial?
To join a fanconi anemia clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are fanconi anemia clinical trials free?
Yes, participation in fanconi anemia clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of fanconi anemia treatments are being studied?
Current fanconi anemia clinical trials are testing a range of approaches across NA (37 studies), PHASE3 (18 studies), PHASE4 (2 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 75 research organizations.
Is it safe to participate in fanconi anemia clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 15, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 15, 2026 · Data from ClinicalTrials.gov